Evidence map

ArticleDiabetes, obesity & metabolism2026

Real-world evaluation of teplizumab in type 1 diabetes: Progression to insulin requirement.

Sahana Mahesh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41424241